ExodusPoint Capital Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.63M | Buy |
+309,021
| New | +$5.63M | 0.05% | 361 |
|
|
2025
Q1 | – | Sell |
-102,351
| Closed | -$1.76M | – | 1334 |
|
|
2024
Q4 | $1.76M | Buy |
+102,351
| New | +$1.76M | 0.01% | 697 |
|
|
2024
Q1 | – | Sell |
-303,596
| Closed | -$1.37M | – | 1325 |
|
|
2023
Q4 | $1.37M | Sell |
303,596
-99,121
| -25% | -$448K | 0.01% | 646 |
|
|
2023
Q3 | $1.44M | Buy |
402,717
+76,948
| +24% | +$276K | 0.01% | 775 |
|
|
2023
Q2 | $1.2M | Buy |
+325,769
| New | +$1.2M | 0.01% | 947 |
|
|
2023
Q1 | – | Sell |
-35,632
| Closed | -$138K | – | 1609 |
|
|
2022
Q4 | $138K | Sell |
35,632
-15,857
| -31% | -$61.4K | ﹤0.01% | 1442 |
|
|
2022
Q3 | $125K | Sell |
51,489
-15,109
| -23% | -$36.7K | ﹤0.01% | 1684 |
|
|
2022
Q2 | $132K | Sell |
66,598
-636,553
| -91% | -$1.26M | ﹤0.01% | 1662 |
|
|
2022
Q1 | $1.29M | Buy |
703,151
+680,953
| +3,068% | +$1.25M | 0.02% | 944 |
|
|
2021
Q4 | $31K | Sell |
22,198
-12,499
| -36% | -$17.5K | ﹤0.01% | 2019 |
|
|
2021
Q3 | $39K | Buy |
+34,697
| New | +$39K | ﹤0.01% | 1933 |
|
|
2021
Q2 | – | Sell |
-92,360
| Closed | -$163K | – | 2201 |
|
|
2021
Q1 | $163K | Sell |
92,360
-5,296
| -5% | -$9.35K | ﹤0.01% | 1862 |
|
|
2020
Q4 | $190K | Buy |
+97,656
| New | +$190K | ﹤0.01% | 1674 |
|
|
2020
Q3 | – | Sell |
-68,050
| Closed | -$199K | – | 1630 |
|
|
2020
Q2 | $199K | Sell |
68,050
-35,163
| -34% | -$103K | 0.01% | 1495 |
|
|
2020
Q1 | $297K | Buy |
+103,213
| New | +$297K | 0.02% | 613 |
|
|
2019
Q2 | – | Sell |
-15,482
| Closed | -$59K | – | 1037 |
|
|
2019
Q1 | $59K | Buy |
+15,482
| New | +$59K | ﹤0.01% | 624 |
|